These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1106 related articles for article (PubMed ID: 789081)

  • 1. Tumor-enhancing and tumor-inhibiting in vivo effects of phytohaemagglutinin. Study on proliferation of transplantable mouse melanoma.
    Schwarze G; Pappas A
    Eur J Cancer (1965); 1976 Aug; 12(8):599-604. PubMed ID: 789081
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 3. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of suppressor cells in mice with a transplantable malignant melanoma.
    Stelzer GT; Wallace JH
    Oncology; 1980; 37(6):397-405. PubMed ID: 6448970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigenicity of Harding-Passey melanoma in transplantation experiments].
    Tritsch H
    Arch Dermatol Forsch; 1972; 245(3):245-53. PubMed ID: 4639777
    [No Abstract]   [Full Text] [Related]  

  • 6. PHA responsiveness of gradient-separated spleen and thymus cells, and the collaborating function of these thymus cells with bone marrow cells.
    Takiguchi T
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):396-410. PubMed ID: 4949296
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on immunization of golden hamsters to transplantable melanomas.
    Bomirski A
    Arch Immunol Ther Exp (Warsz); 1970; 18(4):481-90. PubMed ID: 5483305
    [No Abstract]   [Full Text] [Related]  

  • 8. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunologic reactivity of mice with transplantable Harding-Passey melanoma].
    Kovalev IE; Grigor'ian-Kovaleva VL; Rubtsova ED; Burkin AA; Shaĭdrov VV
    Vopr Onkol; 1971; 17(4):55-8. PubMed ID: 4935523
    [No Abstract]   [Full Text] [Related]  

  • 10. Lectin-resistant variants of mouse melanoma cells. I. Altered metastasizing capacity and tumorigenicity.
    Tao TW; Burger MM
    Int J Cancer; 1982 Apr; 29(4):425-30. PubMed ID: 7085130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.
    Howell SB; Dean JH; Law LW
    Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro.
    Ilfeld D; Carnaud C; Cohen IR; Trainin N
    Int J Cancer; 1973 Jul; 12(1):213-22. PubMed ID: 4133584
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosurveillance of spontaneous lung adenomagenesis in mice.
    Colnaghi MI
    Eur J Cancer (1965); 1975 Sep; 11(9):633-7. PubMed ID: 767117
    [No Abstract]   [Full Text] [Related]  

  • 15. The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients.
    Kumar S; Taylor G
    J Clin Pathol; 1973 Jul; 26(7):476-9. PubMed ID: 4727057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the spleen on tumor growth in mouse lines with various spleen sizes].
    von Wallenberg H; Mainusch P; Meyer J; Hammer C
    Chir Forum Exp Klin Forsch; 1979; ():169-73. PubMed ID: 313319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immunology with particular reference to malignant melanoma.
    Maguire HC
    Int J Dermatol; 1975; 14(1):3-11. PubMed ID: 1092622
    [No Abstract]   [Full Text] [Related]  

  • 18. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. II. Characterization of the cell populations involved in its production and release.
    Hollander N; Iskov N; Segal S; Feldman M
    Int J Cancer; 1978 Oct; 22(4):471-8. PubMed ID: 359491
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of effector cells mediating the antitumor action of glucan.
    Cook JA; Taylor D; Cohen C; Hoffmann EO; Rodrigue J; Malshet V; Di Luzio NR
    J Reticuloendothel Soc; 1977 Jul; 22(1):21-34. PubMed ID: 330854
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of levamisole on in vivo and in vitro murine host response to syngeneic transplantable tumor.
    Fidler IJ; Spitler LE
    J Natl Cancer Inst; 1975 Nov; 55(5):1107-12. PubMed ID: 1206735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.